首页> 美国卫生研究院文献>Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine >Risk of Psychiatric Disorders in Patients with Chronic Insomnia and Sedative-Hypnotic Prescription: A Nationwide Population-Based Follow-Up Study
【2h】

Risk of Psychiatric Disorders in Patients with Chronic Insomnia and Sedative-Hypnotic Prescription: A Nationwide Population-Based Follow-Up Study

机译:慢性失眠和镇静催眠药的患者精神疾病的风险:一项基于全国人口的随访研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Study Objectives:Previous epidemiological studies have established insomnia as a major risk factor for mood, anxiety, and substance use disorders. However, the associations between insomnia with sedative-hypnotic prescriptions and various psychiatric disorders have not been thoroughly examined. The current study involved evaluating the risk of psychiatric disorders, namely schizophrenia, mood, anxiety, somatoform, and substance-related disorders, over a 6-y follow-up period in three groups: patients with insomnia and sedative-hypnotic prescriptions (Inso-Hyp), those with insomnia and without sedative-hypnotic prescriptions (Inso-NonHyp), and those with neither insomnia nor sedative-hypnotic prescriptions (NonInso-NonHyp).
机译:研究目标:先前的流行病学研究已将失眠症定为情绪,焦虑和物质使用失调的主要危险因素。然而,镇静催眠药与失眠症与各种精神病之间的关联尚未得到彻底检查。目前的研究涉及评估精神分裂症,精神分裂症,情绪,焦虑症,躯体形式和与物质有关的疾病等精神疾病的风险,该研究在3年的6年随访期内:失眠和镇静催眠药的患者(Inso- Hyp),没有失眠且没有镇静催眠处方的患者(Inso-NonHyp),以及既没有失眠也没有镇静催眠处方的患者(NonInso-NonHyp)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号